When building your watch list, focus on stocks with an 80 or higher RS Rating. Phreesia is one stock that just reached the mark, now earning a score of 84.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's proprietary RS Rating measures technical performance by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major indexes.
Over 100 years of market history reveals that the market's biggest winners tend to have an RS Rating of above 80 as they launch their biggest price moves.
Phreesia is trying to complete a consolidation with a 30.53 entry. See if it can break out in heavy trade.
The company showed 0% EPS growth last quarter. Revenue increased 15%. Keep an eye out for the company's next round of numbers on or around Sep. 3.
Phreesia holds the No. 5 rank among its peers in the Computer Software-Medical industry group. OptimizeRx is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
